Skip to main content
SpringerLink
Log in

Nontuberculous Mycobacterial Disease: An Introduction and Historical Perspective

  • Chapter
  • First Online:
Nontuberculous Mycobacterial Disease

Part of the book series: Respiratory Medicine ((RM))

Abstract

The serious study of nontuberculous mycobacterial (NTM) disease is a recent development. Although these organisms were identified more than a century ago, it is only within the last few decades that a full appreciation of their importance as human pathogens has become evident. To a large extent, that emergence has been a consequence of new and evolving diagnostic and microbiologic technologies. Progress has also been made in the realm of NTM therapeutics, but it has unfortunately not kept pace with clinical and laboratory advances. Clinicians are all too aware of the obstacles to effective treatment of NTM disease and the limitations of current NTM therapy. Perhaps the greatest challenge is discovering and overcoming the many mechanisms of antibiotic resistance possessed by NTM. There has been remarkable progress in the diagnosis and management of NTM disease in a relatively short period of time with the promise of an accelerated pace for even more significant developments in the near future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119(1):107–59.

    CAS  PubMed  Google Scholar 

  2. Runyon EH. Identification of mycobacterial pathogens utilizing colony characteristics. Am J Clin Pathol. 1970;54(4):578–86.

    Article  CAS  Google Scholar 

  3. Runyon EH. Atypical mycobacteria: their classification. Am Rev Respir Dis. 1965;91:288–9.

    CAS  PubMed  Google Scholar 

  4. Jost KC Jr, Dunbar DF, Barth SS, Headley VL, Elliott LB. Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol. 1995;33(5):1270–7.

    PubMed  PubMed Central  Google Scholar 

  5. Louro AP, Waites KB, Georgescu E, Benjamin WH Jr. Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using AccuProbe. J Clin Microbiol. 2001;39(2):570–3. 8: Pauls RJ, Turenne CY, Wolfe JN, Kabani A. A high proportion of novel mycobacteria species identified by 16S rDNA analysis among slowly growing AccuProbe-negative strains in a clinical setting. Am J Clin Pathol. 2003;120(4):560–6

    Article  CAS  Google Scholar 

  6. Cloud JL, Carroll KC, Cohen S, Anderson CM, Woods GL. Interpretive criteria for use of AccuProbe for identification of Mycobacterium avium complex directly from 7H9 broth cultures. J Clin Microbiol. 2005;43(7):3474–8.

    Article  Google Scholar 

  7. Griffith DE, Brown-Elliott BA, Benwill JL, Wallace RJ Jr. Mycobacterium abscessus. “Pleased to meet you, hope you guess my name...”. Ann Am Thorac Soc. 2015;12(3):436–9.

    Article  Google Scholar 

  8. LPSN. bacterio.net web. List of prokaryotic names with standing in nomenclature. http://www.bacterio.net/-classification.html

  9. Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VC, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM. High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis. 2014;20(3):364–71.

    Article  Google Scholar 

  10. Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Leão SC, Garcia MJ, Vasireddy S, Turenne CY, Griffith DE, Philley JV, Baldan R, Campana S, Cariani L, Colombo C, Taccetti G, Teri A, Niemann S, Wallace RJ Jr, Cirillo DM. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. Int J Syst Evol Microbiol. 2016;66(11):4471–9.

    Article  CAS  Google Scholar 

  11. Adekambi T, Sassi M, van Ingen J, Drancourt M. Reinstating Mycobacterium massiliense and Mycobacterium bolletii as species of the Mycobacterium abscessus complex. Int J Syst Evol Microbiol. 2017;67(8):2726–30.

    Article  CAS  Google Scholar 

  12. van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafrańska A, Hillemann D, Chand M, Schreiber PW, Sommerstein R, Berger C, Genoni M, Rüegg C, Troillet N, Widmer AF, Becker SL, Herrmann M, Eckmanns T, Haller S, Höller C, Debast SB, Wolfhagen MJ, Hopman J, Kluytmans J, Langelaar M, Notermans DW, Ten Oever J, van den Barselaar P, Vonk ABA, Vos MC, Ahmed N, Brown T, Crook D, Lamagni T, Phin N, Smith EG, Zambon M, Serr A, Götting T, Ebner W, Thürmer A, Utpatel C, Spröer C, Bunk B, Nübel U, Bloemberg GV, Böttger EC, Niemann S, Wagner D, Sax H. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017;17(10):1033–41.

    Article  Google Scholar 

  13. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367–76.

    Article  CAS  Google Scholar 

  14. van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat. 2012;15(3):149–61.

    Article  Google Scholar 

  15. Wallace RJ Jr, Iakhiaeva E, Williams MD, Brown-Elliott BA, Vasireddy S, Vasireddy R, Lande L, Peterson DD, Sawicki J, Kwait R, Tichenor WS, Turenne C, Falkinham JO 3rd. Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. J Clin Microbiol. 2013;51(6):1747–52.

    Article  CAS  Google Scholar 

  16. Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O’Brien C, O’Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science. 2016;354(6313):751–7.

    Article  CAS  Google Scholar 

  17. van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D. Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans. Clin Microbiol Infect. 2009;15(10):888–93.

    Article  Google Scholar 

  18. Wallace RJ Jr, Zhang Y, Brown BA, Dawson D, Murphy DT, Wilson R, Griffith DE. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med. 1998;158(4):1235–44.

    Article  Google Scholar 

  19. Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. Chest. 2014;146(2):276–82.

    Article  CAS  Google Scholar 

  20. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987;135(5):1007–14.

    CAS  PubMed  Google Scholar 

  21. O'Brien RJ. The epidemiology of nontuberculous mycobacterial disease. Clin Chest Med. 1989;10(3):407–18.

    CAS  PubMed  Google Scholar 

  22. Griffith DE, Brown-Elliott BA, Wallace RJ Jr. Diagnosing nontuberculous mycobacterial lung disease. A process in evolution. Infect Dis Clin North Am. 2002;16(1):235–49.

    Article  Google Scholar 

  23. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis. 1990;142(4):940–53. Erratum in: Am Rev Respir Dis 1991 Jan;143(1):204.

    Google Scholar 

  24. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical section of the American Lung Association. Am J Respir Crit Care Med. 1997;156(2 Pt 2):S1–25.

    Google Scholar 

  25. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. Review. Erratum in: Am J Respir Crit Care Med 2007 Apr 1;175(7):744–5. Dosage error in article text.

    Article  CAS  Google Scholar 

  26. Jankovic M, Sabol I, Zmak L, Jankovic VK, Jakopovic M, Obrovac M, Ticac B, Bulat LK, Grle SP, Marekovic I, Samarzija M, van Ingen J. Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology. Int J Tuberc Lung Dis. 2016;20(7):934–40.

    Article  CAS  Google Scholar 

  27. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49(12):e124–9.

    Article  Google Scholar 

  28. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182(7):977–82.

    Article  Google Scholar 

  29. Winthrop KL, Varley CD, Ory J, Cassidy PM, Hedberg K. Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA. Emerg Infect Dis. 2011;17(9):1760–1.

    Article  Google Scholar 

  30. Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12(5):642–7.

    Article  Google Scholar 

  31. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881–6.

    Article  Google Scholar 

  32. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970–6.

    Article  Google Scholar 

  33. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Daza R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Tórtola Fernandez T, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop KL, Wagner D, Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–13.

    Article  Google Scholar 

  34. Ito Y, Hirai T, Fujita K, Maekawa K, Niimi A, Ichiyama S, Mishima M. Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan. J Infect Chemother. 2015;21(5):352–6.

    Article  Google Scholar 

  35. Hu P, Bai L, Liu F, Ou X, Zhang Z, Yi S, Chen Z, Gong D, Liu B, Guo J, Tan Y. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China. Chin Med J (Engl). 2014;127(21):3744–5025.

    Google Scholar 

  36. Wu J, Zhang Y, Li J, Lin S, Wang L, Jiang Y, Pan Q, Shen X. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study. PLoS One. 2014;9(10):e109736.

    Article  Google Scholar 

  37. Shao Y, Chen C, Song H, Li G, Liu Q, Li Y, Zhu L, Martinez L, Lu W. The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China. PLoS Negl Trop Dis. 2015;9(3):e0003623.

    Article  Google Scholar 

  38. Wendt SL, George KL, Parker BC, Gruft H, Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. III. Isolation of potentially pathogenic mycobacteria from aerosols. Am Rev Respir Dis. 1980;122(2):259–63.

    CAS  PubMed  Google Scholar 

  39. Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol. 1984;57(2):193–211.

    Article  CAS  Google Scholar 

  40. Parker BC, Ford MA, Gruft H, Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis. 1983;128(4):652–6.

    CAS  PubMed  Google Scholar 

  41. Meissner PS, Falkinham JO 3rd. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. J Infect Dis. 1986;153(2):325–31.

    Article  CAS  Google Scholar 

  42. Fujita K, Ito Y, Hirai T, Maekawa K, Imai S, Tatsumi S, Niimi A, Iinuma Y, Ichiyama S, Mishima M. Genetic relatedness of Mycobacterium avium-intracellulare complex isolates from patients with pulmonary MAC disease and their residential soils. Clin Microbiol Infect. 2013;19(6):537–41.

    Article  CAS  Google Scholar 

  43. Falkinham JO 3rd. Environmental sources of nontuberculous mycobacteria. Clin Chest Med. 2015;36(1):35–41.

    Article  Google Scholar 

  44. Iseman MD, Corpe RF, O'Brien RJ, Rosenzwieg DY, Wolinsky E. Disease due to Mycobacterium avium-intracellulare. Chest. 1985;87(2 Suppl):139S–49S.

    Article  CAS  Google Scholar 

  45. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321(13):863–8.

    Article  CAS  Google Scholar 

  46. Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, Duggal P, Oler AJ, McCormack R, Podack E, Drummond RA, Lionakis MS, Browne SK, Prevots DR, Knowles M, Cutting G, Liu X, Devine SE, Fraser CM, Tettelin H, Olivier KN, Holland SM. Pulmonary nontuberculous mycobacterial infection. A multisystem, multigenic disease. Am J Respir Crit Care Med. 2015;192(5):618–28.

    Article  CAS  Google Scholar 

  47. Chen F, Szymanski EP, Olivier KN, Liu X, Tettelin H, Holland SM, Duggal P. Whole exome sequencing identify the 6q12-q16 linkage region and a candidate gene TTK for pulmonary nontuberculous mycobacterial disease. Am J Respir Crit Care Med. 2017;196:1599.

    Article  CAS  Google Scholar 

  48. Holland SM, Pierce VM, Shailam R, Glomski K, Farmer JR. Case 28-2017. A 13-month-old girl with pneumonia and a 33-year-old woman with hip pain. N Engl J Med. 2017;377(11):1077–91.

    Article  Google Scholar 

  49. Horsburgh CR Jr, Mason UG 3rd, Heifets LB, Southwick K, Labrecque J, Iseman MD. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis. 1987;135(2):418–21.

    CAS  PubMed  Google Scholar 

  50. Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax. 2001;56(3):167–72.

    Article  Google Scholar 

  51. Hawkins CC, Gold JW, Whimbey E, Kiehn TE, Brannon P, Cammarata R, Brown AE, Armstrong D. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986;105(2):184–8.

    Article  CAS  Google Scholar 

  52. Mycobacterioses and the acquired immunodeficiency syndrome. Joint position paper of the American Thoracic Society and the Centers for Disease Control. Am Rev Respir Dis. 1987;136(2):492–6.

    Google Scholar 

  53. Horsburgh CR Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989;139(1):4–7.

    Article  Google Scholar 

  54. Chin DP, Reingold AL, Stone EN, Vittinghoff E, Horsburgh CR Jr, Simon EM, Yajko DM, Hadley WK, Ostroff SM, Hopewell PC. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis. 1994;170(3):578–84.

    Article  CAS  Google Scholar 

  55. Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. N Engl J Med. 1996;335(6):377–83.

    Article  CAS  Google Scholar 

  56. Chaisson RE, Keiser P, Pierce M, Fessel WJ, Ruskin J, Lahart C, Benson CA, Meek K, Siepman N, Craft JC. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. AIDS. 1997;11(3):311–7. PubMed PMID: 9147422.

    Article  CAS  Google Scholar 

  57. Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1766–72.

    Article  Google Scholar 

  58. Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, Steingrube VA, Mazurek GH. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994;149(5):1335–41.

    Article  Google Scholar 

  59. Griffith DE, Brown BA, Girard WM, Murphy DT, Wallace RJ Jr. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clin Infect Dis. 1996;23(5):983–9.

    Article  CAS  Google Scholar 

  60. Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2015;191(1):96–103.

    Article  CAS  Google Scholar 

  61. Kobashi Y, Abe M, Mouri K, Obase Y, Miyashita N, Oka M. Clinical usefulness of combination chemotherapy for pulmonary Mycobacterium avium complex disease. J Infect. 2010;

    Google Scholar 

  62. Kobashi Y, Matsushima T. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan – including a follow-up study. Respiration. 2007;74(4):394–400.

    Article  CAS  Google Scholar 

  63. Olivier KN, Griffith DE, Eagle G, JP MG 2nd, Micioni L, Liu K, Daley CL, Winthrop KL, Ruoss S, Addrizzo-Harris DJ, Flume PA, Dorgan D, Salathe M, Brown-Elliott BA, Gupta R, Wallace RJ Jr. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. Am J Respir Crit Care Med. 2017;195(6):814–23.

    Article  CAS  Google Scholar 

  64. Griffith DE, Eagle G, Thomson RM, Aksamit TA, Hasegawa N, Morimoto K et al. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex. Am J Respir and Crit Care Med, In Press, 2018.

    Google Scholar 

  65. van Ingen J, Ferro BE, Hoefsloot W, Boeree MJ, van Soolingen D. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence. Expert Rev Anti Infect Ther. 2013;11(10):1065–77.

    Article  Google Scholar 

  66. Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25(3):545–82.

    Article  CAS  Google Scholar 

  67. Brown-Elliott BA, Iakhiaeva E, Griffith DE, Woods GL, Stout JE, Wolfe CR, Turenne CY, Wallace RJ Jr. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol. 2013;51(10):3389–94.

    Article  CAS  Google Scholar 

  68. Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ Jr. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;174(8):928–34.

    Article  CAS  Google Scholar 

  69. Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9–16.

    Article  Google Scholar 

  70. van Ingen J, Wagner D, Gallagher J, Morimoto K, Lange C, Haworth CS, Floto RA, Adjemian J, Prevots DR, Griffith DE, NTM-NET. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J. 2017;49(2). pii: 1601855.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Health Science Center, Tyler, TX, USA

    David E. Griffith

Authors
  1. David E. Griffith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David E. Griffith .

Editor information

Editors and Affiliations

  1. Professor of Medicine, University of Texas Health Science Center, Tyler, TX, USA

    David E. Griffith

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Griffith, D.E. (2019). Nontuberculous Mycobacterial Disease: An Introduction and Historical Perspective. In: Griffith, D. (eds) Nontuberculous Mycobacterial Disease. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-93473-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93473-0_1

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-93472-3

  • Online ISBN: 978-3-319-93473-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation